Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease

被引:20
作者
Barker, Michael D. [1 ]
Liddle, John [1 ]
Atkinson, Francis L. [1 ,2 ]
Wilson, David Matthew [1 ,3 ]
Dickson, Marion C. [1 ]
Ramirez-Molina, Cesar [1 ]
Lewis, Huw [1 ]
Davis, Rob P. [1 ]
Somers, Donald O. [1 ]
Neu, Margarete [1 ]
Jones, Emma [1 ]
Watson, Robert [1 ]
机构
[1] GlaxoSmithKline R&D, Med Res Ctr, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England
[2] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England
[3] AstraZeneca, IMED Biotech Unit, Darwin Bldg, Cambridge CB4 0WG, England
关键词
SYK; Spleen Tyrosine Kinase; Lead optimisation; Inhibitor; Skin penetration; Dermal; RHEUMATOID-ARTHRITIS; SYK INHIBITOR;
D O I
10.1016/j.bmcl.2018.09.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery and lead optimisation of a novel series of SYK inhibitors is described. These were optimised for SYK potency and selectivity against Aurora B. Compounds were profiled in a human skin penetration study to identify a suitable candidate molecule for pre-clinical development. Compound 44 (GSK2646264) was selected for progression and is currently in Phase I clinical trials.
引用
收藏
页码:3458 / 3462
页数:5
相关论文
共 16 条
[1]   IMPROVED BACTERIAL TEST SYSTEM FOR DETECTION AND CLASSIFICATION OF MUTAGENS AND CARCINOGENS [J].
AMES, BN ;
LEE, FD ;
DURSTON, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (03) :782-786
[2]  
Atkinson F. L., WO, Patent No. [2010/ 097248, 2010097248]
[3]   The structure, regulation, and function of ZAP-70 [J].
Au-Yeung, Byron B. ;
Deindl, Sebastian ;
Hsu, Lih-Yun ;
Palacios, Emil H. ;
Levin, Susan E. ;
Kuriyan, John ;
Weiss, Arthur .
IMMUNOLOGICAL REVIEWS, 2009, 228 :41-57
[4]   Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors [J].
Garton, Neil S. ;
Barker, Michael D. ;
Davis, Rob P. ;
Douault, Clement ;
Hooper-Greenhill, Edward ;
Jones, Emma ;
Lewis, Huw D. ;
Liddle, John ;
Lugo, Dave ;
McCleary, Scott ;
Preston, Alex G. S. ;
Ramirez-Molina, Cesar ;
Neu, Margarete ;
Shipley, Tracy J. ;
Somers, Don O. ;
Watson, Robert J. ;
Wilson, David M. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) :4606-4612
[5]   Spleen tyrosine kinase: An Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases [J].
Ghosh, Debjani ;
Tsokos, George C. .
AUTOIMMUNITY, 2010, 43 (01) :48-55
[6]   Ligand efficiency: a useful metric for lead selection [J].
Hopkins, AL ;
Groom, CR ;
Alex, A .
DRUG DISCOVERY TODAY, 2004, 9 (10) :430-431
[7]   Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor [J].
Liddle, John ;
Atkinson, Francis L. ;
Barker, Michael D. ;
Carter, Paul S. ;
Curtis, Neil R. ;
Davis, Rob P. ;
Douault, Clement ;
Dickson, Marion C. ;
Elwes, Dorothy ;
Garton, Neil S. ;
Gray, Matthew ;
Hayhow, Thomas G. ;
Hobbs, Clare I. ;
Jones, Emma ;
Leach, Stuart ;
Leavens, Karen ;
Lewis, Huw D. ;
McCleary, Scott ;
Neu, Margarete ;
Patel, Vipulkumar K. ;
Preston, Alex G. S. ;
Ramirez-Molina, Cesar ;
Shipley, Tracy J. ;
Skone, Philip A. ;
Smithers, Nick ;
Somers, Donald O. ;
Walker, Ann L. ;
Watson, Robert J. ;
Weingarten, Gordon G. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) :6188-6194
[8]  
Lucas MC, 2014, FUTURE MED CHEM, V6, P1811, DOI [10.4155/FMC.14.126, 10.4155/fmc.14.126]
[9]   An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment [J].
Meltzer, EO ;
Berkowitz, RB ;
Grossbard, EB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (04) :791-796
[10]   The SYK tyrosine kinase: a crucial player in diverse biological functions [J].
Mocsai, Attila ;
Ruland, Juergen ;
Tybulewicz, Victor L. J. .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (06) :387-402